Global Blood Therapeutics Inc (NASDAQ:GBT)

North American company

Market Info

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info

  • Market Cap$2.812bn
  • SymbolNASDAQ:GBT
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS37890U1088

Company Profile

Global Blood Therapeutics Inc is a clinical-stage biopharmaceutical company in the United States. Its major focus lies on developing therapeutics for the treatment of blood-based disorders such as red blood cell sickling.